Cargando…

Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals

Since early 2022, various Omicron variants have dominated the SARS-CoV-2 pandemic in most countries. All Omicron variants are B-cell immune escape variants, and antibodies induced by first-generation COVID-19 vaccines or by infection with earlier SARS-CoV-2 variants largely fail to protect individua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barros-Martins, Joana, Hammerschmidt, Swantje I., Morillas Ramos, Gema, Cossmann, Anne, Hetzel, Laura, Odak, Ivan, Köhler, Miriam, Stankov, Metodi V., Ritter, Christiane, Friedrichsen, Michaela, Ravens, Inga, Schimrock, Anja, Ristenpart, Jasmin, Janssen, Anika, Willenzon, Stefanie, Bernhardt, Günter, Lichtinghagen, Ralf, Bošnjak, Berislav, Behrens, Georg M. N., Förster, Reinhold
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196199/ https://www.ncbi.nlm.nih.gov/pubmed/37215123 http://dx.doi.org/10.3389/fimmu.2023.1166589

Ejemplares similares

Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
por: Barros-Martins, Joana, et al.
Publicado: (2021)

BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
por: Behrens, Georg M. N., et al.
Publicado: (2022)

Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of Concern
por: Odak, Ivan, et al.
Publicado: (2022)

Robust induction of neutralizing antibodies against the SARS‐CoV‐2 Delta variant after homologous Spikevax or heterologous Vaxzevria‐Spikevax vaccination
por: Hammerschmidt, Swantje I., et al.
Publicado: (2022)

Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination
por: Hammerschmidt, Swantje I., et al.
Publicado: (2021)

The effect of Toll-like receptor agonists on the immunogenicity of MVA-SARS-2-S vaccine after intranasal administration in mice
por: Do, Kim Thi Hoang, et al.
Publicado: (2023)

Hide and seek with SARS-CoV-2: spike receptor-binding domain-specific memory B cells still recognize Omicron variant
por: Odak, Ivan, et al.
Publicado: (2022)

Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy
por: Jedicke, Nils, et al.
Publicado: (2021)

Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals
por: Behrens, Georg M. N., et al.
Publicado: (2020)

Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage
por: Arora, Prerna, et al.
Publicado: (2023)

Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents
por: Bošnjak, Berislav, et al.
Publicado: (2021)

Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods
por: Bošnjak, Berislav, et al.
Publicado: (2020)

Efficient IL-2R signaling differentially affects the stability, function, and composition of the regulatory T-cell pool
por: Permanyer, Marc, et al.
Publicado: (2021)

NK cell dysfunction in severe COVID-19: TGF-β-induced downregulation of integrin beta-2 restricts NK cell cytotoxicity
por: Barros-Martins, Joana, et al.
Publicado: (2022)

SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination
por: Behrens, Georg MN, et al.
Publicado: (2021)

Application of light sheet microscopy for qualitative and quantitative analysis of bronchus-associated lymphoid tissue in mice
por: Mzinza, David Twapokera, et al.
Publicado: (2018)

Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals
por: Behrens, Georg M. N., et al.
Publicado: (2020)

Challenges of CRISPR-Based Gene Editing in Primary T Cells
por: Rezalotfi, Alaleh, et al.
Publicado: (2022)

CRISPR/Cas9 Immunoengineering of Hoxb8-Immortalized Progenitor Cells for Revealing CCR7-Mediated Dendritic Cell Signaling and Migration Mechanisms in vivo
por: Hammerschmidt, Swantje I., et al.
Publicado: (2018)

Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5
por: Arora, Prerna, et al.
Publicado: (2022)

IL-17–induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs
por: Fleige, Henrike, et al.
Publicado: (2014)

Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell Therapy
por: Bošnjak, Berislav, et al.
Publicado: (2021)

Distinct gene expression patterns correlate with developmental and functional traits of iNKT subsets
por: Georgiev, Hristo, et al.
Publicado: (2016)

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis
por: Strengert, Monika, et al.
Publicado: (2021)

Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination
por: Dulovic, Alex, et al.
Publicado: (2022)

Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients
por: Becker, Matthias, et al.
Publicado: (2022)

Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?
por: Gussarow, Daniel, et al.
Publicado: (2021)

Cardiomyocytes display low mitochondrial priming and are highly resistant toward cytotoxic T‐cell killing
por: Zheng, Xiang, et al.
Publicado: (2016)

Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage
por: Nehlmeier, Inga, et al.
Publicado: (2023)

Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo
por: Hammerschmidt, Swantje I., et al.
Publicado: (2008)

Efficient homing of T cells via afferent lymphatics requires mechanical arrest and integrin-supported chemokine guidance
por: Martens, Rieke, et al.
Publicado: (2020)

SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination
por: Arora, Prerna, et al.
Publicado: (2022)

The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency
por: Arora, Prerna, et al.
Publicado: (2021)

The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
por: Arora, Prerna, et al.
Publicado: (2022)

Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1
por: Sidarovich, Anzhalika, et al.
Publicado: (2022)

Shared and Unique Features Distinguishing Follicular T Helper and Regulatory Cells of Peripheral Lymph Node and Peyer’s Patches
por: Georgiev, Hristo, et al.
Publicado: (2018)

Omicron spike protein: a clue for viral entry and immune evasion
por: Behrens, G. M. N., et al.
Publicado: (2022)

Dynamic interactome of the MHC I peptide loading complex in human dendritic cells
por: Barends, Martina, et al.
Publicado: (2023)

Autolysosomal activation combined with lysosomal destabilization efficiently targets myeloid leukemia cells for cell death
por: Shah, Harshit, et al.
Publicado: (2023)

Reappearance of effector T cells is associated with recovery from COVID-19
por: Odak, Ivan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l8svibjnhhofvuus3cjr9ud6uu